Scientific Conferences for The College on Problems of Drug Dependence (CPDD)

药物依赖问题学院科学会议（CPDD）

• 批准号: 10377420
• 负责人: William Walton Stoops
• 金额: $ 9.5万
• 依托单位: COLLEGE ON PROBLEMS OF DRUG DEPENDENCE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10377420
• 关键词: AIDS/HIV problem; Academia; Address; Administrator; Adopted; Alcohols; Animals; Anti-Anxiety Agents; Area; Award; Behavior; Cannabis; Career Mobility; Clinical; Collaborations; Computer software; Country; Development; Discipline; Drug Addiction; Epidemiology; Equipment; Fostering; Funding; Future; Genetic; Government; Grant; Hallucinogens; Health Services; Human; Industry; International; Knowledge; Learning; Medicine; Mentors; Mission; Molecular Biology; National Institute of Drug Abuse; Nature; Neurosciences; Nicotine; Nurses; Online Systems; Opioid; Participant; Pharmaceutical Chemistry; Pharmaceutical Preparations; Pharmacology; Physicians; Policies; Policy Maker; Prevention; Psychologist; Psychology; Public Health; Public Policy; Research; Research Personnel; Scientific Societies; Scientist; Sociology; Stimulant; Students; Substance Use Disorder; Training Activity; Travel; Underrepresented Minority; Underrepresented Populations; United States; addiction; career; career development; college; drug of abuse; epidemiology study; experience; health disparity; hypnotic; improved; innovation; interest; lectures; meetings; neuroimaging; outreach; posters; pre-doctoral; programs; research study; sedative; substance use; substance use treatment; symposium; translational study; treatment research; virtual

ABSTRACT This is a request for a 5-year renewal of grant R13DA013192 to continue to support travel awards for trainees and early career researchers to attend annual meetings of the College on Problems of Drug Dependence (CPDD). CPDD is the oldest scientific society dedicated to substance use research. As the only annual national or international meeting that brings together researchers studying all aspects and approaches to the problems of substance use, CPDD’s conference provides a particularly enriching experience for trainees and early career researchers in the field. The meeting attracts basic and clinical researchers from throughout the United States and about 40 countries, at all career stages from predoctoral students through senior investigators, as well as representatives from government and industry. It includes scientists, physicians, nurses, clinical psychologists, administrators, policy makers, journalists and others working on or interested in substance use research. Our meetings are a forum for researchers from a broad range of disciplines (e.g., medicinal chemistry, molecular biology, pharmacology, genetics, neuroimaging, psychology, sociology, addiction medicine, public health, epidemiology) to share their recent findings, network and learn from one another in formal and informal exchanges. We expect 1000-1300 attendees at each of our future meetings supported by this competing renewal. In the next funding period, we propose to continue to support travel awards for trainees and early career researchers to attend the CPDD annual meetings. Topics addressed at the meeting change with emerging concerns and cutting-edge research in the field, and, each year, sessions highly relevant to NIDA's major program areas (e.g., epidemiology, prevention, health services, medications development, neuroscience, behavior, HIV/AIDS and health disparities) are included. Presentations span the full range of drugs of abuse, including opioids, stimulants, sedatives, cannabis, hallucinogens, nicotine and alcohol. The conference includes awards lectures and forums on policy, animal and human research, industry/academia/government collaboration and media outreach, as well as activities directed towards trainees, early career researchers, underrepresented minorities and international scientists. We expect our annual meetings to accelerate innovation in substance use research through the translational nature of our content and through the collaborations that are built between attendees across the disciplines represented at the meeting. We also expect findings presented at the meeting to reach a broader audience due to our media outreach activities and newly developed virtual offerings, which can significantly improve prevention and treatment of substance use disorders and inform policy as it relates to substance use.

抽象的 这是一项将拨款 R13DA013192 续签 5 年的请求，以继续支持以下人员的旅行奖励： 学员和早期职业研究人员参加毒品问题学院年会 依赖性（CPDD）。 CPDD 是最古老的致力于药物滥用研究的科学协会。作为 唯一汇集研究各个方面的研究人员的年度国内或国际会议 和解决物质使用问题的方法，CPDD 会议提供了一个特别的 丰富该领域学员和早期职业研究人员的经验。会议吸引了基层 以及来自美国各地和约 40 个国家/地区各个职业阶段的临床研究人员 从博士前学生到高级研究人员，以及来自政府和机构的代表 行业。它包括科学家、医生、护士、临床心理学家、管理人员、政策制定者、 从事药物使用研究或对药物使用研究感兴趣的记者和其他人。我们的会议是一个论坛 来自广泛学科的研究人员（例如药物化学、分子生物学、 药理学、遗传学、神经影像学、心理学、社会学、成瘾医学、公共卫生、 流行病学）以正式和非正式的方式分享他们的最新发现、建立联系并相互学习 交流。我们预计未来每次会议将有 1000-1300 名与会者参加 竞争更新。在下一个资助期内，我们建议继续支持旅行奖励 学员和早期职业研究人员参加 CPDD 年会。会议讨论的主题 应对该领域新出现的问题和前沿研究的变化，并且每年， 与 NIDA 的主要计划领域（例如流行病学、预防、健康 服务、药物开发、神经科学、行为、艾滋病毒/艾滋病和健康差异） 包括。演示涵盖了各种滥用药物，包括阿片类药物、兴奋剂、镇静剂、 大麻、致幻剂、尼古丁和酒精。会议包括颁奖讲座和论坛 政策、动物和人类研究、工业/学术界/政府合作和媒体宣传， 以及针对受训人员、早期职业研究人员、代表性不足的少数群体的活动 和国际科学家。我们期望我们的年会能够加速物质使用方面的创新 通过我们内容的翻译性质和建立的合作进行研究 参加会议的各个学科的与会者之间。我们也期待调查结果 由于我们的媒体宣传活动和新的 开发虚拟产品，可以显着改善药物滥用的预防和治疗 疾病并为与药物使用相关的政策提供信息。